Thomas J. Herzfeld Advisors, Inc. Crispr Therapeutics Ag Transaction History

Thomas J. Herzfeld Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $28,368 - $36,875	625 New	625 $28.4 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $11,967 - $17,829	225 Added 56.25%	625 $39,000
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $1,653 - $2,349	-15 Reduced 3.61%	400 $45,000
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $201 - $323	-2 Reduced 0.48%	415 $67,000
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $44,288 - $84,016	400 Added 2352.94%	417 $51,000
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $1,334 - $1,710	17 New	17 $2,000

489

57.9M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.16B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.